Ipsen logo

Senior Manager, Global Late-Stage Partnering (Business Development)

Ipsen

Cambridge, MAOnsitePosted 19 days ago$112,500 - $165,000
Full TimeMid LevelCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

The Senior Manager, Global Late-Stage Partnering will be a member of the Global Late-Stage Partnering team and report directly to the Vice President, Head of Late-Stage Partnering. The Senior Manager will lead and maintain Ipsen's Late-Stage Opportunity Intelligence process across Oncology, Rare Diseases, and Neuroscience, developing a comprehensive view of the external partnering landscape and identifying and prioritizing potential business development opportunities.

Job description

The role will coordinate insights from cross-functional stakeholders across R&D, Medical Affairs, Commercial, Finance, and Legal to assess the strategic fit and attractiveness of external programs and companies. The individual will translate complex scientific, clinical, commercial, and competitive information into actionable insights, strategic analyses, and executive-level recommendations to support portfolio planning and partnering decisions.

Main Responsibilities

External Opportunity Landscape Management

  • Own and maintain a comprehensive, continuously updated landscape of late-stage partnering opportunities across Oncology, Rare Diseases, and Neuroscience.
  • Develop and manage a systematic process for identifying, tracking, evaluating, and prioritizing external assets and companies of strategic interest.
  • Monitor the external environment to identify emerging opportunities, competitive developments, strategic transactions, and shifts in market dynamics that may impact Ipsen's business development priorities.
  • Establish and maintain tools, databases, dashboards, and reporting mechanisms that provide visibility into the external opportunity universe.
  • Serve as the internal owner of the external opportunity universe and ensure opportunity assessments remain current, organized, and actionable.

Monitoring Program Value Inflection Points

  • Track, analyze, and maintain a forward-looking view of key clinical, regulatory, commercial, corporate, and financing milestones for programs and companies of strategic interest.
  • Proactively communicate important developments and their potential implications to the Global Late-Stage Partnering team and relevant internal stakeholders.

Internal Stakeholder Engagement and Insight Generation

  • Build and maintain strong working relationships with leaders and subject matter experts across the Oncology, Rare Diseases, and Neuroscience therapeutic areas.
  • Serve as the primary coordinator for gathering, consolidating, and maintaining Ipsen's perspectives on externally monitored assets and companies.
  • Maintain institutional knowledge of previous opportunity evaluations and strategic discussions.

Strategic Business Development and Transaction Support

  • Provide ad hoc support on selected late-stage business development transactions, including opportunity assessments, diligence preparation, competitive analyses, valuation support, and preparation of internal decision-making materials.
  • Participate in transaction teams as appropriate, gaining exposure to the evaluation and execution of strategic licensing, acquisition, and collaboration opportunities.

Knowledge & Experience

  • 3–7 years of experience in business development, competitive intelligence, corporate strategy, management consulting, equity research, portfolio strategy, or the biopharmaceutical industry.
  • Experience evaluating external assets, technologies, or pipeline opportunities is highly desirable.
  • Demonstrated ability to work effectively in cross-functional environments and manage multiple priorities simultaneously.
  • Bachelor's or Master's degree in a scientific, medical, or business discipline required.
  • Advanced scientific degree (PhD, PharmD, MD) and/or MBA preferred.

Behavioral Competencies Required

  • Strong understanding of the pharmaceutical and biotechnology industry, including drug development, regulatory pathways, commercialization, and business development.
  • Ability to evaluate scientific, clinical, commercial, competitive, and strategic dimensions of external opportunities.
  • Excellent analytical and critical-thinking skills with the ability to synthesize large volumes of information into clear, actionable insights.
  • Strong attention to detail while maintaining a strategic enterprise-wide perspective.
  • Ability to identify emerging trends and anticipate events that could influence partnering strategy and priorities.
  • Ability to establish credibility and work effectively with stakeholders across multiple functions and organizational levels.
  • Strong interpersonal and relationship-building skills.
  • Excellent written and verbal communication skills.
  • Ability to coordinate cross-functional input and drive alignment around opportunity assessments and recommendations.
  • Ability to communicate complex information effectively to senior executives and governance bodies.
  • Strong executive communication and presentation development skills, including preparation of Board-level materials.
  • Demonstrated ability to influence without direct authority and operate effectively in a highly matrixed global organization.

Requirements

  • 3–7 years of experience in business development, competitive intelligence, corporate strategy, management consulting, equity research, portfolio strategy, or the biopharmaceutical industry.
  • Experience evaluating external assets, technologies, or pipeline opportunities is highly desirable.
  • Demonstrated ability to work effectively in cross-functional environments and manage multiple priorities simultaneously.
  • Bachelor's or Master's degree in a scientific, medical, or business discipline required.
  • Advanced scientific degree (PhD, PharmD, MD) and/or MBA preferred.
  • Strong understanding of the pharmaceutical and biotechnology industry, including drug development, regulatory pathways, commercialization, and business development.
  • Ability to evaluate scientific, clinical, commercial, competitive, and strategic dimensions of external opportunities.
  • Excellent analytical and critical-thinking skills with the ability to synthesize large volumes of information into clear, actionable insights.
  • Strong attention to detail while maintaining a strategic enterprise-wide perspective.
  • Ability to identify emerging trends and anticipate events that could influence partnering strategy and priorities.
  • Ability to establish credibility and work effectively with stakeholders across multiple functions and organizational levels.
  • Strong interpersonal and relationship-building skills.
  • Excellent written and verbal communication skills.
  • Ability to coordinate cross-functional input and drive alignment around opportunity assessments and recommendations.
  • Ability to communicate complex information effectively to senior executives and governance bodies.
  • Strong executive communication and presentation development skills, including preparation of Board-level materials.
  • Demonstrated ability to influence without direct authority and operate effectively in a highly matrixed global organization.

Benefits

  • 401(k) Matching
  • Medical, Dental & Vision
  • Life Insurance
  • Disability Insurance
  • Flexible Spending Accounts
  • Parental Leave
  • Paid Time Off
  • Winter Shutdown
  • Well-being Allowance
  • Commuter Benefits

Company overview

Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a global presence in over 40 countries. Founded in 1929 by Henri Beaufour, the company has evolved into a leading mid-size pharmaceutical firm specializing in three key therapeutic areas: oncology, rare diseases, and neuroscience. With approximately 5,300 employees worldwide, Ipsen operates as a publicly traded company on Euronext Paris while maintaining significant family ownership through the Beaufour family. The company's portfolio includes innovative treatments such as Cabometyx for advanced cancers, Dysport for neurological conditions, and Bylvay for rare liver diseases. Ipsen has established itself as one of the world's top 15 biopharmaceutical companies in oncology sales, with medicines registered in 88 countries and direct commercial operations in over 30 nations. The company maintains four global R&D hubs and three pharmaceutical development centers, investing significantly in research and development to advance transformative medicines for patients with limited treatment options.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.